Zymeworks board member Renton to resign Dec 10, 2024; Gallagher and Mahony appointed to compensation committee

Zymeworks Inc.

Hollings C. Renton resigns from board and as compensation committee chair, effective Dec 10, 2024 (annual meeting date).
Resignation not due to any disagreement with the company on operations, policies or practices.
Dr. Neil Gallagher appointed to compensation committee; Dr. Susan Mahony named committee chair.
Committee composition updated: Mahony (Compensation chair), Gallagher (member), others unchanged.

item 5.02 item 8.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Hollings C. Renton

Director

ZYME · Zymeworks Inc.

Effective: 2024-12-10
Filed: October 18, 2024, 7:59 PM ET

Mr. Hollings C. Renton submitted his resignation from the board of directors (the “Board”) of Zymeworks Inc. (the “Company”), including as chair and member of the Board’s compensation committee, effective December 10, 2024

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Hollings C. Renton resigned as Director at Zymeworks Inc..

Action: resigned
Role: Director

Exact text from the filing

Mr. Hollings C. Renton submitted his resignation from the board of directors (the “Board”) of Zymeworks Inc. (the “Company”), including as chair and member of the Board’s compensation committee, effective December 10, 2024

View on SEC.gov

Zymeworks Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-239630

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.